Clinical Trial

Surveillance of AMR in DRC

Study acronym: SARKIN
Recruiting
View on ClinicalTrials.gov →
Summary
This study addresses knowledge gaps regarding antimicrobial resistance (AMR) in sub-Saharan Africa, focusing on evaluating the feasibility of AMR surveillance and enhancing local research capacity. Conducted at a general referral hospital in semirural Kinshasa, DRC, the study will investigate bacterial infections, their resistance profiles, and related risk factors, including co-infections such as malaria.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-03-30 -> 2026-09-30 2026-07-24
minor Completion pushed: 2025-09-30 -> 2026-09-30 2026-07-24
Trial Details
NCT Number NCT06821282
Lead Sponsor University of Oxford
Collaborators: University of Kinshasa, Mahidol University, Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo, Department of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia
Conditions Bacteremia
Enrollment 210 participants
Start Date 2024-11-11
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-23